Lucira Health, Inc. (CIK: 0001652724) EDGAR, Information, Filings... CompaniesBIO.Com

Lucira Health, Inc.

Mailing address
1412 62ND STREET, EMERYVILLE, Delaware, 94608
Phone
(814) 574-1546
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

Lucira Health, Inc. (CIK: 0001652724) is an American company incorporated in the state of California. Head office is located at 1412 62ND STREET, EMERYVILLE, California, 94608. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. Lucira Health, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Boeding Chad	0001779451	Dec-14-2022	other: CEO of 10% owner
EPIQ Capital Group, LLC	0001779453	Dec-14-2022	10 percent owner
EPQ LLC, LFLU PS	0001798799	Dec-14-2022	other: Less than 10% owner
EPQ LLC, LCOVD PS	0001818376	Dec-14-2022	10 percent owner
EPQ LLC, LCOVD SAFE PS	0001833912	Dec-14-2022	other: Less than 10% owner
EPQ LLC, LTEST PS	0001841495	Dec-14-2022	other: Less than 10% Owner
Narido Richard Clavano	0001956050	Dec-01-2022	officer: Interim CFO
McCauley Alison	0001899652	Dec-17-2021	director
Allen Anthony Joseph	0001882773	Sep-20-2021	officer: Chief Operations Officer
Kashmolah Ghazi	0001877741	Aug-16-2021	officer: Ex. VP &Chief Quality Officer
Collins Kevin Walter	0001870312	Jun-24-2021	officer: Chief Revenue Officer
GARDINER SANDRA A.	0001218574	Feb-04-2021	director
Eclipse Ventures Fund I, L.P.	0001641394	Feb-04-2021	10 percent owner
HARTMANN HANSGREGORY C.	0001645080	Feb-04-2021	officer: Chief Operating Officer
Eclipse Fund III, L.P.	0001763853	Feb-04-2021	10 percent owner
Eclipse GP III, LLC	0001763854	Feb-04-2021	10 percent owner
Rogers Erica J.	0001769940	Feb-04-2021	director
Lamond David	0001770790	Feb-04-2021	director
Yen Tuff	0001832420	Feb-04-2021	director
Prashar Tamanna	0001832525	Feb-04-2021	officer: Vice President
Mitra Debkishore	0001832529	Feb-04-2021	director, officer: Chief Technology Officer
Susan Lior	0001832895	Feb-04-2021	director, 10 percent owner
Engelson Erik T.	0001839384	Feb-04-2021	director, officer: President and Chief Executive
George Dan	0001840534	Feb-04-2021	officer: CFO and Treasurer
Tablak Steve	0001841554	Feb-04-2021	director
Lewis Brezoczky Kelly	0001843226	Feb-04-2021	officer: Executive Vice President
Eclipse Ventures GP I, LLC	0001843678	Feb-04-2021	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Lucira Health, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001193125-23-213430 (34 Act) Size: 22 KB	Aug-15-2023	001-39976 231174805
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-178587 (33 Act) Size: 19 KB	Jun-29-2023	333-252839 231057452
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-178576 (33 Act) Size: 19 KB	Jun-29-2023	333-264237 231057410
8-K	Document	Current report filing Acc-no: 0001193125-23-165269 (34 Act) Size: 1188 KB	Jun-12-2023	001-39976 231008003
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001193125-23-146069 (34 Act) Size: 21 KB	May-16-2023	001-39976 23927377
8-K	Document	Current report filing Acc-no: 0001193125-23-112839 (34 Act) Size: 173 KB	Apr-24-2023	001-39976 23840082
8-K	Document	Current report filing Acc-no: 0001193125-23-104988 (34 Act) Size: 597 KB	Apr-18-2023	001-39976 23826924
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001193125-23-100639 (34 Act) Size: 21 KB	Apr-13-2023	001-39976 23818860
25-NSE	Document	Acc-no: 0001354457-23-000269 (34 Act) Size: 3 KB	Apr-12-2023	001-39976
8-K	Document	Current report filing Acc-no: 0001193125-23-096507 (34 Act) Size: 146 KB	Apr-10-2023	001-39976 23811125
8-K	Document	Current report filing Acc-no: 0001193125-23-092209 (34 Act) Size: 2279 KB	Apr-05-2023	001-39976 23802532
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-018261 ( Act) Size: 11 KB	Mar-13-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-018225 ( Act) Size: 10 KB	Mar-13-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-018223 ( Act) Size: 5 KB	Mar-13-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-018219 ( Act) Size: 4 KB	Mar-13-2023
8-K	Document	Current report filing Acc-no: 0001193125-23-050739 (34 Act) Size: 182 KB	Feb-27-2023	001-39976 23674655
8-K	Document	Current report filing Acc-no: 0001193125-23-044968 (34 Act) Size: 172 KB	Feb-22-2023	001-39976 23654646
8-K	Document	Current report filing Acc-no: 0001193125-23-043480 (34 Act) Size: 146 KB	Feb-21-2023	001-39976 23648078
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-011047 ( Act) Size: 4 KB	Feb-21-2023
8-K	Document	Current report filing Acc-no: 0001193125-23-008374 (34 Act) Size: 171 KB	Jan-13-2023	001-39976 23528953

Recent 20 filings. View all Lucira Health, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Lucira Health, Inc. overview
Lucira Health, Inc. job
Lucira Health, Inc. stock
Lucira Health, Inc. ownership
Lucira Health, Inc. CEO
Lucira Health, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.